A comprehensive forced degradation studies of Cariprazine hydrochloride using LC-HRMS/MS and in silico toxicity predictions of its degradation products
Authors:
- 21 July 2022
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 219, 114955
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Identification of hydrolytic and isomeric N-oxide degradants of vilazodone by on line LC–ESI–MS/MS and APCI–MSJournal of Pharmaceutical and Biomedical Analysis, 2015
- Critical practical aspects in the application of liquid chromatography–mass spectrometric studies for the characterization of impurities and degradation productsJournal of Pharmaceutical and Biomedical Analysis, 2014
- Orbitrap Mass SpectrometryAnalytical Chemistry, 2013
- Characterization of impurities in tylosin using dual liquid chromatography combined with ion trap mass spectrometryTalanta, 2013
- Cariprazine: chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerabilityExpert Opinion on Drug Metabolism & Toxicology, 2012
- A novel reverse phase stability indicating RP-UPLC method for the quantitative determination of fifteen related substances in Ranolazine drug substance and drug productTalanta, 2012
- Identification and structural elucidation of two process impurities and stress degradants in darifenacin hydrobromide active pharmaceutical ingredient by LC-ESI/MSnThe Analyst, 2012
- Sensitive LC–MS/MS methods for the quantification of RGH-188 and its active metabolites, desmethyl- and didesmethyl-RGH-188 in human plasma and urineJournal of Pharmaceutical and Biomedical Analysis, 2008
- Kinetics and mechanism of hydrolysis of phenylureasJournal of the Chemical Society, Perkin Transactions 2, 2002
- Photolytic demethylation of monuron and demethylmonuron in aqueous solutionPesticide Science, 1982